These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 18673131)

  • 21. Synthesis and SAR of aminopyrimidines as novel c-Jun N-terminal kinase (JNK) inhibitors.
    Alam M; Beevers RE; Ceska T; Davenport RJ; Dickson KM; Fortunato M; Gowers L; Haughan AF; James LA; Jones MW; Kinsella N; Lowe C; Meissner JW; Nicolas AL; Perry BG; Phillips DJ; Pitt WR; Platt A; Ratcliffe AJ; Sharpe A; Tait LJ
    Bioorg Med Chem Lett; 2007 Jun; 17(12):3463-7. PubMed ID: 17459703
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live-cell imaging and profiling of c-Jun N-terminal kinases using covalent inhibitor-derived probes.
    Qian L; Pan S; Lee JS; Ge J; Li L; Yao SQ
    Chem Commun (Camb); 2019 Jan; 55(8):1092-1095. PubMed ID: 30620026
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses.
    Nacken W; Ehrhardt C; Ludwig S
    Biol Chem; 2012 May; 393(6):525-34. PubMed ID: 22628315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of small-molecule inhibitors of the JIP-JNK interaction.
    Chen T; Kablaoui N; Little J; Timofeevski S; Tschantz WR; Chen P; Feng J; Charlton M; Stanton R; Bauer P
    Biochem J; 2009 May; 420(2):283-94. PubMed ID: 19243309
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Alkyl chain substituted 1,9-pyrazoloanthrones exhibit prominent inhibitory effect on c-Jun N-terminal kinase (JNK).
    Prasad KD; Trinath J; Biswas A; Sekar K; Balaji KN; Guru Row TN
    Org Biomol Chem; 2014 Jul; 12(26):4656-62. PubMed ID: 24853961
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel c-Jun N-Terminal Kinase (JNK) Inhibitors with an 11
    Liakhov SA; Schepetkin IA; Karpenko OS; Duma HI; Haidarzhy NM; Kirpotina LN; Kovrizhina AR; Khlebnikov AI; Bagryanskaya IY; Quinn MT
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34577159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitors.
    He Y; Kamenecka TM; Shin Y; Song X; Jiang R; Noel R; Duckett D; Chen W; Ling YY; Cameron MD; Lin L; Khan S; Koenig M; LoGrasso PV
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1719-23. PubMed ID: 21316221
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and SAR of novel isoxazoles as potent c-jun N-terminal kinase (JNK) inhibitors.
    He Y; Duckett D; Chen W; Ling YY; Cameron MD; Lin L; Ruiz CH; Lograsso PV; Kamenecka TM; Koenig M
    Bioorg Med Chem Lett; 2014 Jan; 24(1):161-4. PubMed ID: 24332487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tetra-substituted pyridinylimidazoles as dual inhibitors of p38α mitogen-activated protein kinase and c-Jun N-terminal kinase 3 for potential treatment of neurodegenerative diseases.
    Muth F; Günther M; Bauer SM; Döring E; Fischer S; Maier J; Drückes P; Köppler J; Trappe J; Rothbauer U; Koch P; Laufer SA
    J Med Chem; 2015 Jan; 58(1):443-56. PubMed ID: 25475894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and structure-activity relationship studies of thiophene-3-carboxamide derivatives as dual inhibitors of the c-Jun N-terminal kinase.
    De SK; Barile E; Chen V; Stebbins JL; Cellitti JF; Machleidt T; Carlson CB; Yang L; Dahl R; Pellecchia M
    Bioorg Med Chem; 2011 Apr; 19(8):2582-8. PubMed ID: 21458276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the MKK7-JNK (Mitogen-Activated Protein Kinase Kinase 7-c-Jun N-Terminal Kinase) Pathway with Covalent Inhibitors.
    Wolle P; Hardick J; Cronin SJF; Engel J; Baumann M; Lategahn J; Penninger JM; Rauh D
    J Med Chem; 2019 Mar; 62(5):2843-2848. PubMed ID: 30768270
    [TBL] [Abstract][Full Text] [Related]  

  • 32. JNK pathway signaling: a novel and smarter therapeutic targets for various biological diseases.
    Kumar A; Singh UK; Kini SG; Garg V; Agrawal S; Tomar PK; Pathak P; Chaudhary A; Gupta P; Malik A
    Future Med Chem; 2015; 7(15):2065-86. PubMed ID: 26505831
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of c-Jun N-terminal kinase as a therapeutic target for abdominal aortic aneurysm.
    Yoshimura K; Aoki H; Ikeda Y; Furutani A; Hamano K; Matsuzaki M
    Ann N Y Acad Sci; 2006 Nov; 1085():403-6. PubMed ID: 17182964
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure-driven HtL: design and synthesis of novel aminoindazole inhibitors of c-Jun N-terminal kinase activity.
    Stocks MJ; Barber S; Ford R; Leroux F; St-Gallay S; Teague S; Xue Y
    Bioorg Med Chem Lett; 2005 Jul; 15(14):3459-62. PubMed ID: 15950471
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct inhibition of c-Jun N-terminal kinase in sympathetic neurones prevents c-jun promoter activation and NGF withdrawal-induced death.
    Eilers A; Whitfield J; Shah B; Spadoni C; Desmond H; Ham J
    J Neurochem; 2001 Mar; 76(5):1439-54. PubMed ID: 11238729
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of a novel series of 4-quinolone JNK inhibitors.
    Gong L; Tan YC; Boice G; Abbot S; McCaleb K; Iyer P; Zuo F; Dal Porto J; Wong B; Jin S; Chang A; Tran P; Hsieh G; Niu L; Shao A; Reuter D; Lukacs CM; Ursula Kammlott R; Kuglstatter A; Goldstein D
    Bioorg Med Chem Lett; 2012 Dec; 22(24):7381-7. PubMed ID: 23142618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A c-Jun NH2-terminal kinase inhibitor SP600125 (anthra[1,9-cd]pyrazole-6 (2H)-one) blocks activation of pancreatic stellate cells.
    Masamune A; Kikuta K; Suzuki N; Satoh M; Satoh K; Shimosegawa T
    J Pharmacol Exp Ther; 2004 Aug; 310(2):520-7. PubMed ID: 15056726
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of potent, highly selective, and orally bioavailable pyridine carboxamide c-Jun NH2-terminal kinase inhibitors.
    Zhao H; Serby MD; Xin Z; Szczepankiewicz BG; Liu M; Kosogof C; Liu B; Nelson LT; Johnson EF; Wang S; Pederson T; Gum RJ; Clampit JE; Haasch DL; Abad-Zapatero C; Fry EH; Rondinone C; Trevillyan JM; Sham HL; Liu G
    J Med Chem; 2006 Jul; 49(15):4455-8. PubMed ID: 16854050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of a novel JNK (c-Jun N-terminal kinase) inhibitory peptide.
    Ngoei KR; Catimel B; Church N; Lio DS; Dogovski C; Perugini MA; Watt PM; Cheng HC; Ng DC; Bogoyevitch MA
    Biochem J; 2011 Mar; 434(3):399-413. PubMed ID: 21162712
    [TBL] [Abstract][Full Text] [Related]  

  • 40. c-Jun N-terminal kinases as potential therapeutic targets.
    Salh B
    Expert Opin Ther Targets; 2007 Oct; 11(10):1339-53. PubMed ID: 17907963
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.